Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-19-059171
Filing Date
2019-11-04
Accepted
2019-11-04 06:05:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a19-21684_1sc13da.htm SC 13D/A 46775
2 EX-7.04 a19-21684_1ex7d04.htm EX-7.04 1173233
  Complete submission text file 0001104659-19-059171.txt   1221549
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Filed by) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13D/A

Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44(0)207 400 3347
Myovant Sciences Ltd. (Subject) CIK: 0001679082 (see all company filings)

EIN.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-89732 | Film No.: 191188172
SIC: 2834 Pharmaceutical Preparations